Calcium Folinate Injection 50 mg/5 mL vial

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

calcium folinate, Quantity: 10.8 mg/mL (Equivalent: calcium folinate, Qty 10 mg/mL; Equivalent: folinic acid, Qty 10 mg/mL)

Available from:

Hospira Australia Pty Ltd

INN (International Name):

Calcium folinate

Pharmaceutical form:

Injection

Composition:

Excipient Ingredients: hydrochloric acid; water for injections; sodium chloride; sodium hydroxide

Administration route:

Intramuscular, Intravenous Infusion

Units in package:

1 x 5 mL vial

Class:

Medicine Listed (Export Only)

Prescription type:

(S1) This Schedule is intentionally blank

Therapeutic indications:

Calcium Leucovorin is indicated in:a) Neutralising the immediate toxic effects of folic acid antagonists, e.g. Methotrexate b) Calcium Leucovorin Rescue - a treatment technique using Calcium Leucovorin in conjunction with folic acid antagonists, e.g. Methotrexate, to minimise systemic toxicity. c) The treatment of megaloblastic anaemias due to sprue, nutritional deficiency, pregnancy, infancy, liver disease and malabsorption syndrome.

Product summary:

Visual Identification: A clear, straw to pale yellow coloured solution, free from particulate matter; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Child resistant closure and restricted flow insert

Authorization status:

Listed (Export Only)

Authorization date:

2007-06-13